CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.190
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT - Market closed

CureVac Statistics

Total Valuation

CureVac has a market cap or net worth of $718.25 million. The enterprise value is $256.45 million.

Market Cap 718.25M
Enterprise Value 256.45M

Important Dates

The last earnings date was Thursday, April 10, 2025, before market open.

Earnings Date Apr 10, 2025
Ex-Dividend Date n/a

Share Statistics

CureVac has 225.16 million shares outstanding. The number of shares has increased by 1.57% in one year.

Current Share Class 225.16M
Shares Outstanding 225.16M
Shares Change (YoY) +1.57%
Shares Change (QoQ) n/a
Owned by Insiders (%) 5.64%
Owned by Institutions (%) 16.96%
Float 125.69M

Valuation Ratios

The trailing PE ratio is 4.28.

PE Ratio 4.28
Forward PE n/a
PS Ratio 1.29
Forward PS n/a
PB Ratio 0.99
P/TBV Ratio 1.03
P/FCF Ratio 7.22
P/OCF Ratio 6.78
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.11, with an EV/FCF ratio of 2.59.

EV / Earnings 1.53
EV / Sales 0.46
EV / EBITDA 1.11
EV / EBIT 1.18
EV / FCF 2.59

Financial Position

The company has a current ratio of 7.28, with a Debt / Equity ratio of 0.06.

Current Ratio 7.28
Quick Ratio 7.11
Debt / Equity 0.06
Debt / EBITDA 0.17
Debt / FCF 0.41
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 26.73% and return on invested capital (ROIC) is 20.26%.

Return on Equity (ROE) 26.73%
Return on Assets (ROA) 16.48%
Return on Invested Capital (ROIC) 20.26%
Return on Capital Employed (ROCE) 28.72%
Revenue Per Employee $563,656
Profits Per Employee $170,816
Employee Count 983
Asset Turnover 0.67
Inventory Turnover 8.34

Taxes

In the past 12 months, CureVac has paid $29.71 million in taxes.

Income Tax 29.71M
Effective Tax Rate 15.03%

Stock Price Statistics

The stock price has increased by +26.09% in the last 52 weeks. The beta is 2.48, so CureVac's price volatility has been higher than the market average.

Beta (5Y) 2.48
52-Week Price Change +26.09%
50-Day Moving Average 3.09
200-Day Moving Average 3.19
Relative Strength Index (RSI) 54.64
Average Volume (20 Days) 695,455

Short Selling Information

The latest short interest is 4.85 million, so 2.15% of the outstanding shares have been sold short.

Short Interest 4.85M
Short Previous Month 4.06M
Short % of Shares Out 2.15%
Short % of Float 3.86%
Short Ratio (days to cover) 7.67

Income Statement

In the last 12 months, CureVac had revenue of $554.07 million and earned $167.91 million in profits. Earnings per share was $0.75.

Revenue 554.07M
Gross Profit 444.71M
Operating Income 217.19M
Pretax Income -297.84M
Net Income 167.91M
EBITDA 230.42M
EBIT 217.19M
Earnings Per Share (EPS) $0.75
Full Income Statement

Balance Sheet

The company has $498.76 million in cash and $40.34 million in debt, giving a net cash position of $458.41 million or $2.04 per share.

Cash & Cash Equivalents 498.76M
Total Debt 40.34M
Net Cash 458.41M
Net Cash Per Share $2.04
Equity (Book Value) 721.20M
Book Value Per Share 3.21
Working Capital 470.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $105.45 million and capital expenditures -$14.82 million, giving a free cash flow of $99.04 million.

Operating Cash Flow 105.45M
Capital Expenditures -14.82M
Free Cash Flow 99.04M
FCF Per Share $0.44
Full Cash Flow Statement

Margins

Gross margin is 80.26%, with operating and profit margins of 39.20% and 30.30%.

Gross Margin 80.26%
Operating Margin 39.20%
Pretax Margin 35.67%
Profit Margin 30.30%
EBITDA Margin 41.59%
EBIT Margin 39.20%
FCF Margin 17.88%

Dividends & Yields

CureVac does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.57%
Shareholder Yield -1.57%
Earnings Yield 23.49%
FCF Yield 13.85%
Dividend Details

Analyst Forecast

The average price target for CureVac is $10.00, which is 213.48% higher than the current price. The consensus rating is "Buy".

Price Target $10.00
Price Target Difference 213.48%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) -13.85%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CureVac has an Altman Z-Score of 3.55 and a Piotroski F-Score of 6.

Altman Z-Score 3.55
Piotroski F-Score 6